SCHEMBL7369499

SCHEMBL7369499

COc1cc(-c2csc(N)n2)cc([N+](=O)[O-])c1O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.54
NPC1 O15118 5/20 0.54
SMN1; SMN2 Q16637 5/20 0.54
RAB9A P51151 4/20 0.54
RECQL P46063 3/20 0.54
LMNA P02545 1/20 0.54
ALDH1A1 P00352 6/20 0.53
POLB P06746 5/20 0.53
KMT2A Q03164 4/20 0.53
MEN1 O00255 3/20 0.53
MAPK1 P28482 2/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53
LARS1 Q9P2J5 1/20 0.50
GRK6 P43250 1/20 0.46
MCL1 Q07820 2/20 0.43
CSNK2A2 P19784 1/20 0.43
CSNK2B P67870 1/20 0.43
CSNK2A1 P68400 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31084656 0.82 MAPT (0.72) MAPTNPC1SMN1; SMN2RAB9ARECQL
SCHEMBL3134094 0.82 MAPT (0.72) MAPTNPC1SMN1; SMN2RAB9ARECQL
Bromide SCHEMBL7368429 0.82 MAPT (0.54) MAPTNPC1SMN1; SMN2RAB9ARECQL
SCHEMBL7366431 0.79 LARS1 (0.57) MAPTNPC1SMN1; SMN2RAB9ARECQL
SCHEMBL6199409 0.79 ALDH1A1 (0.57) MAPTNPC1SMN1; SMN2RAB9AALDH1A1
SCHEMBL27428414 0.73 ALDH1A1 (0.59) MAPTNPC1SMN1; SMN2RAB9ARECQL
SCHEMBL7363044 0.73 ALDH1A1 (0.59) MAPTNPC1SMN1; SMN2RAB9AALDH1A1
SCHEMBL7374010 0.72 MAPT (0.66) MAPTNPC1SMN1; SMN2RAB9ARECQL
SCHEMBL7367333 0.72 MAPT (0.49) MAPTNPC1SMN1; SMN2RAB9ALMNA
SCHEMBL25239669 0.71 MAPT (0.81) MAPTNPC1SMN1; SMN2RAB9ARECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed